Q53Z42 (Q53Z42_HUMAN) Homo sapiens (Human)

MHC class I antigen UniProtKBInterProInteractive Modelling

365 aa; Sequence (Fasta)

Available Structures

13 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
SARS-CoV-2 Spike-derived peptide S417-425 K417T mutant (TIADYNYKL) presented by HLA-A*02:01 Heteromer
P0DTC2; P61769;
25-300
ZN;CD;NA;
Assess
SARS-CoV-2 Spike-derived peptide S1185-1193 K1191N mutant (RLNEVANNL) presented by HLA-A*02:01 Heteromer
P0DTC2; P61769;
25-300
CD;ZN;NA;ACT;CL;
Assess
SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLGFIAGL) presented by HLA-A*02:01 Heteromer
P0DTC2; P61769;
25-300
Assess
CryoEM structure of HLA-A2 bound to MAGEA4 (230-239) peptide Heteromer
P61769;
25-300
Assess
CryoEM structure of HLA-A2 bound to MAGEA8 (232-241) peptide Heteromer
25-300
Assess
HCMV US11 peptide binding to HLA-A*02:01 Heteromer
P61769;
25-299
GOL;CD;PGE;
Assess
Structure of HLA-A*0201 complexed with peptide Md3-C9 derived from a clustering region of restricte… Heteromer
P59596; P61769;
25-299
Assess
Human Class I MHC HLA-A2 in complex with sorting nexin 24 (127-135) neoantigen KLSHQLVLL Heteromer
P61769; Q9Y343;
25-299
PEG;GOL;
Assess
Alpha-beta TCR Binding to Neoantigen KQWLVWLFL Presented by HLA-A206 Heteromer
P61769; Q5VTY9;
25-299
GOL;
Assess
Crystal structure of HLA A2*01-AVYDGREHTV Heteromer
P43358; P61769;
25-298
EDO;
Assess
SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 Heteromer
P0DTC2; P61769;
25-298
Assess
YLQ-SG3 TCR in complex with SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-… Heteromer
P0DTC2; P61769;
25-298
NA;
Assess
Crystal structure of the T-cell receptor GVY01 bound to HLA A2*01-GVYDGREHTV Heteromer
P43358; P61769;
26-298
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7u1r.1.Amonomer0.8525-300
ARG;100.00
Assess